Daily non-political popular news in brief.
Triptolide: A potential drug for polycystic kidney disease
03-05-2007 · EurekAlert!A treatment for polycystic kidney disease (PKD), a leading cause of fatal kidney failure worldwide, has been identified by a research team led by Yale biochemist Craig Crews, according to a report in the Proceedings of the National Academy of Sciences.
Read more »
Keywords: triptolide, potential, drug, polycystic, kidney, disease
« Previous | Next »
Similar news on "Triptolide: A potential drug for polycystic kidney disease":
- Kidney Progress: Drug slows cyst growth
11-25-2006 · Science News Online
The trial drug roscovitine has been shown to reverse polycystic kidney disease in mice.
Similar news · Read more »
- Enzyme may hold key to new treatment of diabetic kidney disease
11-07-2006 · EurekAlert!
Northwestern University researchers have found an enzyme, called "ACE2," may hold the potential to treat diabetic kidney disease, the most common form of kidney disease.The researchers have found low levels of the ACE2 enzyme in kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease.
Similar news · Read more »
- Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease
11-12-2007 · EurekAlert!
Molecular biologists at Jefferson's Kimmel Cancer Center in Philadelphia have detailed the cascade of cellular events behind some potentially dangerous autoinflammatory diseases. In doing so, they not only have gained a greater understanding of the disease process, but have also identified new potential drug targets for diseases ranging from arthritis to cancer.
Similar news · Read more »
- Pioglitazone lowers cardiovascular risk in diabetic patients with kidney disease
12-12-2007 · EurekAlert!
A new study confirms that chronic kidney disease increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the antidiabetic drug pioglitazone may help to lower this risk, reports the January Journal of the American Society of Nephrology.
Similar news · Read more »
- TXNIP -- Regulator of glucose homeostasis and potential diabetes drug target and more
04-30-2007 · EurekAlert!
Glucose homeostasis, the appropriate balancing of blood sugar levels, is impaired early in patients who become diabetic, causing life-threatening complications such as kidney failure and heart attacks. A study of the mechanisms of glucose homeostasis and early diabetes has dentified a key regulator of glucose homeostasis in humans.
Similar news · Read more »
- Study identifies novel Parkinson's disease drug target
06-21-2007 · EurekAlert!
Researchers at the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) have identified a potential new drug target for the treatment of Parkinson's disease and possibly for other degenerative neurological disorders.
Similar news · Read more »
- Researchers investigate ways to detect lupus-associated kidney disease
11-13-2007 · EurekAlert!
High urinary levels of certain molecules might have the potential to serve as biomarkers for a potentially life-shortening kidney ailment caused by the autoimmune disease lupus, UT Southwestern Medical Center researchers have found.
Similar news · Read more »
- A potential new disease-modifying drug for osteoarthritis
07-30-2007 · EurekAlert!
oral calcitonin may effectively protect postmenopausal women from the ongoing pain and ultimate disability of joint destruction.
Similar news · Read more »
- Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
11-09-2007 · EurekAlert!
Researchers at Children's Hospital of Pittsburgh of UPMC are participating in an international clinical trial currently underway to study the effectiveness of oral insulin in preventing or delaying the onset of type 1 diabetes in people at risk for the disease.
Similar news · Read more »
- Experimental drug shows promise in advanced kidney cancer
09-26-2007 · EurekAlert!
A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
Similar news · Read more »
